SRE:BMVSempra Analysis
Data as of 2026-05-18 - not real-time
$90.43
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sempra (SRE) trades at $90.43, below its 20‑day SMA of 93.03 and 50‑day SMA of 94.64, indicating short‑term weakness, while the RSI of 38.4 hints at modest oversold pressure. The MACD is in a bearish configuration (line –0.84 vs signal –0.65) and the price sits near the technical support at $89.62, with resistance around $96.06. Fundamental metrics show a trailing PE of 30.76 versus an industry average of 21.30, suggesting the stock is currently overvalued relative to peers, and the DCF fair value of $14.61 underscores this gap. Despite a dividend yield of 2.91%, the payout ratio is high at 88% and free cash flow is deeply negative (‑$28.2 B), raising concerns about dividend sustainability. The balance sheet is leveraged, with a debt‑to‑equity of 85.3 and a beta below 0.4, reflecting low market volatility but heightened financial risk. Recent news confirms Q1 earnings in line with estimates and a consensus “Buy” rating with a median price target of $104, implying a modest 15% upside, yet the underlying cash‑flow strain tempers enthusiasm.
Looking ahead, the utility’s regulated segments provide stable revenue streams, and the infrastructure arm offers growth potential, but the combination of high leverage, negative free cash flow, and an elevated valuation makes the near‑term outlook cautious. The “Extreme Greed” market sentiment (Fear‑Greed Index 88.45) may be inflating price expectations, while the stock’s low beta and modest 30‑day volatility (≈19.7%) limit downside risk. Investors should weigh the attractive dividend against the sustainability concerns and consider the stock as a borderline hold, with a preference for medium‑term upside if the company can improve cash generation and reduce debt.
Looking ahead, the utility’s regulated segments provide stable revenue streams, and the infrastructure arm offers growth potential, but the combination of high leverage, negative free cash flow, and an elevated valuation makes the near‑term outlook cautious. The “Extreme Greed” market sentiment (Fear‑Greed Index 88.45) may be inflating price expectations, while the stock’s low beta and modest 30‑day volatility (≈19.7%) limit downside risk. Investors should weigh the attractive dividend against the sustainability concerns and consider the stock as a borderline hold, with a preference for medium‑term upside if the company can improve cash generation and reduce debt.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term SMA
- Proximity to technical support at $89.62
- Elevated valuation relative to peers
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus “Buy” with median target $104 (+15% upside)
- Stable regulated revenue and dividend yield
- Potential improvement in forward PE to 16.3
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Long‑term regulated utility cash‑flow stability
- High leverage and negative free cash flow limiting upside
- Infrastructure investments offering growth but requiring capital
Key Metrics & Analysis
Financial Health
Revenue Growth-3.90%
Profit Margin14.43%
P/E Ratio30.8
ROE5.69%
ROA1.81%
Debt/Equity85.27
P/B Ratio1.9
Op. Cash Flow$4.9B
Free Cash Flow$-28243374080
Industry P/E21.3
Technical Analysis
TrendNeutral
RSI38.4
Support$89.62
Resistance$96.06
MA 20$93.03
MA 50$94.64
MA 200$90.01
MACDBearish
VolumeIncreasing
Fear & Greed Index88.45
Valuation
Fair Value$14.61
Target Price$104.24
Upside/Downside15.27%
GradeOvervalued
TypeBlend
Dividend Yield2.91%
Risk Assessment
Beta0.39
Volatility19.72%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.